1. Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer;Chamie;Urol. Oncol.,2015
2. Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer;Ding;Zhonghua zhong liu za zhi Chin. J. Oncol.,2018
3. The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guerin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis;Ye;OncoTargets Ther.,2018
4. [Topoisomerase II inhibitors (anthracyclines)];Sato;Nihon rinsho Japan. J. Clin. Med.,2015
5. Anthracyclines as topoisomerase II poisons: from early studies to new perspectives;Marinello;Int. J. Mol. Sci.,2018